Search - tctmd.com

Displaying 141 - 160 of 201

Sort: Relevancy | Date

News Daily News

El Cierre del AAI con Amplatzer parece Seguro y Eficaz en Pacientes con FA

Yael L. Maxwell

November 06, 2014

Presentation Cardiovascular Interventions 2014

Left Atrial Appendage Closure for Atrial Fibrillation

Presenter: Matthew J. Price

October 23, 2014

News Daily News

Time May Be Running Out for Watchman Amid Weak Support From FDA Panel

L.A. McKeown

October 16, 2014

Presentation TCT 2014

Cost-effectiveness Analysis Of Left Atrial Appendage Occlusion Device Compared With 7 Oral Anticoagulants For Stroke Prevention In Atrial Fibrillation

Presenter: Vivian Lee

September 16, 2014

Presentation TCT 2014

TCT 170: Cost-effectiveness Analysis of a Left Atrial Appendage Occlusion Device Compared with 7 Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation

Presenter: Saibal Kar, Bushra S Rana, Jai-Wun Park, Vivian Lee

September 15, 2014

Presentation TCT 2014

Current (and Future) Guidelines for Atrial Fibrillation Treatment

Presenter: Josep Rodés-Cabau, Brian K. Whisenant, David Hildick-Smith, Ted E. Feldman

September 15, 2014

Presentation TCT 2014

Stroke, Bleeding, and Risk Scores in Atrial Fibrillation

Presenter: Josep Rodés-Cabau, Brian K. Whisenant, David Hildick-Smith, Stefan C. Bertog

September 15, 2014

Presentation TCT 2014

Putting it All Together: Anticoagulants, Rhythm Control, and LAA Closure Which Therapy for Which Patient?

Presenter: Matthew J. Price, Shephal Doshi

September 15, 2014

Presentation TCT 2014

Shifting the Treatment Paradigm with LAA Closure: Efficacy, Complications, and Future Challenges

Presenter: Matthew J. Price

September 15, 2014

Presentation TCT 2014

Can LAA Closure Become the New Standard for Stroke Prevention?

Presenter: Hilary Nierenberg, Julie Logan, Saibal Kar

September 14, 2014

News Conference News TCT 2014

LAA Closure Edges Out Medical Therapy for Cost-effectiveness in AF

September 14, 2014

Presentation TCT 2014

Percutaneous Left Atrial Appendage Closure for Atrial Fibrillation: Where Are We Compared to New Drugs and Ablation

Presenter: Jose Luis Assad-Morell, Efrain Gaxiola, Matthew J. Price

September 13, 2014

Presentation LAA 2014

Atrial Fibrillation in Patient with Low Bleeding Risk

Presenter: John D. Carroll

July 19, 2014

Presentation LAA 2014

Atrial Fibrillation and LAA Closure in a Patient Requiring PCI

Presenter: Matthew J. Price

July 19, 2014

Presentation LAA 2014

Quantifying stroke and bleeding risk in atrial fibrillation

Presenter: Stefan Bertog

July 17, 2014

News Daily News

PREVAIL Published: Watchman, Warfarin Show Comparable Stroke Protection in A-fib

July 03, 2014

News Daily News

PREVAIL Publicado: Watchman y Warfarina Ofrecen Protección Similar Frente a los ACV en Pacientes con FA

July 03, 2014

News Conference News EuroPCR 2014

Benefit of LAA Closure Becomes Most Evident After 1 Year

Caitlin E. Cox

May 23, 2014

Presentation EuroPCR 2014

Two-year clinical outcome after left atrial appendage closure with the Amplatzer Cardiac Plug device in patients with non-valvular atrial fibrillation and contraindications for anticoagulation therapy

Presenter: Jos? Ram?n L?pez-M?nguez

May 21, 2014

Presentation Fellows 2014

LAA Closure for Nonvalvular Atrial Fibrillation

Presenter: William Gray

April 14, 2014

Advertisement

El Cierre del AAI con Amplatzer parece Seguro y Eficaz en Pacientes con FA

Left Atrial Appendage Closure for Atrial Fibrillation

Time May Be Running Out for Watchman Amid Weak Support From FDA Panel

Cost-effectiveness Analysis Of Left Atrial Appendage Occlusion Device Compared With 7 Oral Anticoagulants For Stroke Prevention In Atrial Fibrillation

TCT 170: Cost-effectiveness Analysis of a Left Atrial Appendage Occlusion Device Compared with 7 Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation

Current (and Future) Guidelines for Atrial Fibrillation Treatment

Stroke, Bleeding, and Risk Scores in Atrial Fibrillation

Putting it All Together: Anticoagulants, Rhythm Control, and LAA Closure Which Therapy for Which Patient?

Shifting the Treatment Paradigm with LAA Closure: Efficacy, Complications, and Future Challenges

Can LAA Closure Become the New Standard for Stroke Prevention?

LAA Closure Edges Out Medical Therapy for Cost-effectiveness in AF

Percutaneous Left Atrial Appendage Closure for Atrial Fibrillation: Where Are We Compared to New Drugs and Ablation

Atrial Fibrillation in Patient with Low Bleeding Risk

Atrial Fibrillation and LAA Closure in a Patient Requiring PCI

Quantifying stroke and bleeding risk in atrial fibrillation

PREVAIL Published: Watchman, Warfarin Show Comparable Stroke Protection in A-fib

PREVAIL Publicado: Watchman y Warfarina Ofrecen Protección Similar Frente a los ACV en Pacientes con FA

Benefit of LAA Closure Becomes Most Evident After 1 Year

Two-year clinical outcome after left atrial appendage closure with the Amplatzer Cardiac Plug device in patients with non-valvular atrial fibrillation and contraindications for anticoagulation therapy

LAA Closure for Nonvalvular Atrial Fibrillation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content